Corteva price target raised to $72 from $70 at Oppenheimer

Oppenheimer analyst Kristen Owen raised the firm’s price target on Corteva (CTVA) to $72 from $70 and keeps an Outperform rating on the shares. The firm sees Corteva coming into 2025 with the benefits of its diversified portfolio, technology differentiation, and self-help drivers, positioning it for healthy 10% margin and earnings growth. The updated outlook was broadly in line with expectations, and Oppenheimer believes offers the potential for upside should stronger global trait penetration materialize.